Enlivex Completes 1-for-16 Reverse Split, Shares Trade Split-Adjusted from October 27

summarizeSummary

Enlivex's 1-for-16 reverse split took effect October 27, reducing shares outstanding from 24,511,905 to about 1,531,995. It addresses the sub-$1 bid price behind the recent Nasdaq delisting notice but does not by itself resolve the listing problem.

check_boxKey Events · Corporate Governance and Compliance · ENLV

• 1-for-16 Reverse Split Effective

  Every 16 ordinary shares were combined into one, with trading on a split-adjusted basis on Nasdaq from October 27, 2026 under the same ENLV symbol and new CUSIP M4130Y205.

• Share Count Cut to ~1.53M

  Issued and outstanding shares fell from 24,511,905 to approximately 1,531,995, and authorized shares from 158,333,333 to 9,895,833, with par value raised from NIS 6.00 to NIS 96.00.

• Warrants and Options Adjusted

  A proportionate adjustment was made to the exercise price and share count of all outstanding warrants and options; the Lind note and ATM overhang remain in place economically.

• Listing Risk Still Open

  The split follows the October 27 Nasdaq delisting notice for a bid price below $1.00 over 30 business days, which the company said came with no cure period.

auto_awesomeAnalysis · ENLV · Crypto Assets

The reverse split shareholders authorized on October 22 is now final at 1-for-16 and effective, cutting the share count from 24,511,905 to roughly 1,531,995 and lifting the implied price about 16x. That is the mechanical fix for the $1.00 bid-price problem behind the October 27 Nasdaq delisting notice, but it does not cure the underlying issue: the notice came with no cure period, so the company still has to demonstrate a sustained compliant bid. Existing holders own the same percentage of a much smaller share count, and every outstanding warrant and option is adjusted proportionally, so the dilution overhang from the Lind note and the ATM program is unchanged in economic terms.